Dr James Pang, Research Fellow
Turner Institute for Brain and Mental Health, Monash University
VICTORIA, AUSTRALIA
Bench Side Story continues with a Research Fellow at the Turner Institute for Brain and Mental Health, at Monash University in Melbourne, Victoria, Australia.
Dr James Pang received his PhD in Physics from the University of Sydney and completed his postdoctoral training in the Brain Modelling Group at QIMR Berghofer Medical Research Institute (Brisbane, Australia). He is currently a Research Fellow at the Turner Institute for Brain and Mental Health, School of Psychological Sciences. His research employs a multidisciplinary approach that combines biophysical models, neuroimaging, and connectivity to better understand the mechanisms of brain function in health, disease, and across species.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
-
Mental wellbeing in rural and regional communities dealing with environmental challenges
Associate Professor Suzie Cosh is a psychologist and clinical researcher. Her work focuses on the intersection of climate change and mental health and she currently leads a body of work that focuses on supporting small rural communities to recover from and prepare for extreme weather events such as bushfires, floods and droughts.
-
CASE STUDY Link between levels of extracellular vesicles in the blood and tissue damage caused by diseases
A landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better detect the level of tissue damage in our bodies.
This study revealed, for the first time, a link between levels of EVs in the blood and tissue damage caused by diseases such as leukaemia.
Researchers hope to leverage the critical new insight to develop a blood test to monitor cancer patients with tissue damage, which could, in future, enhance treatment strategies for blood cancers and other diseases.
